Biosecurity Modernization and Innovation Act aims to enhance security in nucleic acid synthesis in interstate and foreign commerce.

The Biosecurity Modernization and Innovation Act mandates the Secretary of Commerce to consult with stakeholders to identify best practices for nucleic acid synthesis security. Covered entities must establish protocols to verify buyers, establish risk-based criteria for sales, and report high-risk transactions. The Secretary can initiate civil actions for violations, with penalties up to $750,000 per violation. The Act also requires regular reports on economic competitiveness and national security risks, and preempts state laws related to these requirements.

Biosecurity Modernization and Innovation Act aims to enhance security in nucleic acid synthesis in interstate and foreign commerce.

The Biosecurity Modernization and Innovation Act mandates the Secretary of Commerce to consult with stakeholders to identify best practices for nucleic acid synthesis security. Covered entities must establish protocols to verify buyers, establish risk-based criteria for sales, and report high-risk transactions. The Secretary can initiate civil actions for violations, with penalties up to $750,000 per violation. The Act also requires regular reports on economic competitiveness and national security risks, and preempts state laws related to these requirements.